FIELD: medicine, therapy, radiobiology. SUBSTANCE: invention proposes a novel agent used for early pathogenetic therapy of radiation damages. The known vasodilator molsidomin (sydnoimine or N-carboxy-3-morpholino-sydnoimine ethyl ester) is used as this agent. Agent can be used by orally route, it shows good tolerance, the presence of tabletting form of drug with prolonged storage. EFFECT: enhanced effectiveness of agent, improved properties. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
RADIOPROTECTIVE AGENT | 1997 |
|
RU2179020C2 |
RADIO-PROTECTING DEVICE | 1996 |
|
RU2144357C1 |
AGENT FOR PREVENTION OF CEREBRAL FORM OF ACUTE RADIATION SICKNESS | 2022 |
|
RU2797835C1 |
METHOD OF APPLYING VEGETABLE POLYSACCHARIDE AS RADIOPROTECTOR AND STIMULATOR OF COLONY FORMATION OF SPLEEN STEM CELLS IN IRRADIATED ANIMALS | 2013 |
|
RU2537033C1 |
AGENT FOR EARLY PATHOGENETIC THERAPY OF ACUTE RADIATION DISEASE | 2003 |
|
RU2281092C2 |
METHOD OF EVALUATION OF SHIELDING PROPERTIES OF RADIATION PROTECTIVE CLOTHING | 1998 |
|
RU2153785C1 |
AGENT POSSESSING SELECTIVE RADIO- AND CHEMOPROTECTIVE ACTION | 2007 |
|
RU2339386C1 |
METHOD FOR REDUCING MORTALITY FROM RADIATION EXPOSURE IN EXPERIMENTAL ANIMALS | 2018 |
|
RU2677592C1 |
METHOD FOR PREVENTING AND TREATING ACUTE RADIATION INJURY | 2021 |
|
RU2770991C2 |
METHOD OF TREATING ACUTE RADIATION SICKNESS | 2008 |
|
RU2385731C1 |
Authors
Dates
2001-03-20—Published
1998-10-13—Filed